Lymphomatoid papulosis associated with parathyroid nodular hyperplasia: report of a case
Corresponding Author
M Aguilar-Bernier
Department of Dermatology, Hospital Universitario, Avda.Ramon y Cajal, 3. 47005 Valladolid, Spain.
*Corresponding author, Department of Dermatology. Hospital Universitario, Avda.Ramon y Cajal, 3. 47005 Valladolid, Spain, tel. +34655752285; fax +34983257511; E-mail: [email protected]Search for more papers by this authorJ Bassas-Vila
Department of Dermatology, Hospital Universitario, Avda.Ramon y Cajal, 3. 47005 Valladolid, Spain.
Search for more papers by this authorMT Bordel-Gomez
Department of Dermatology, Hospital Universitario, Avda.Ramon y Cajal, 3. 47005 Valladolid, Spain.
Search for more papers by this authorA Morales-Callaghan
Department of Dermatology, Hospital Universitario, Avda.Ramon y Cajal, 3. 47005 Valladolid, Spain.
Search for more papers by this authorJA Tejerina-Garcia
Department of Dermatology, Hospital Universitario, Avda.Ramon y Cajal, 3. 47005 Valladolid, Spain.
Search for more papers by this authorA Miranda-Romero
Department of Dermatology, Hospital Universitario, Avda.Ramon y Cajal, 3. 47005 Valladolid, Spain.
Search for more papers by this authorCorresponding Author
M Aguilar-Bernier
Department of Dermatology, Hospital Universitario, Avda.Ramon y Cajal, 3. 47005 Valladolid, Spain.
*Corresponding author, Department of Dermatology. Hospital Universitario, Avda.Ramon y Cajal, 3. 47005 Valladolid, Spain, tel. +34655752285; fax +34983257511; E-mail: [email protected]Search for more papers by this authorJ Bassas-Vila
Department of Dermatology, Hospital Universitario, Avda.Ramon y Cajal, 3. 47005 Valladolid, Spain.
Search for more papers by this authorMT Bordel-Gomez
Department of Dermatology, Hospital Universitario, Avda.Ramon y Cajal, 3. 47005 Valladolid, Spain.
Search for more papers by this authorA Morales-Callaghan
Department of Dermatology, Hospital Universitario, Avda.Ramon y Cajal, 3. 47005 Valladolid, Spain.
Search for more papers by this authorJA Tejerina-Garcia
Department of Dermatology, Hospital Universitario, Avda.Ramon y Cajal, 3. 47005 Valladolid, Spain.
Search for more papers by this authorA Miranda-Romero
Department of Dermatology, Hospital Universitario, Avda.Ramon y Cajal, 3. 47005 Valladolid, Spain.
Search for more papers by this authorThe authors have no conflict of interests to disclose, and no funding sources.
ABSTRACT
The association of cutaneous lymphoproliferative diseases and primary hyperparathyroidism (PHP) is infrequent, with only three cases reported to date. We present a patient with lymphomatoid papulosis (LyP) who developed hypercalcaemia secondary to parathyroid nodular hyperplasia. A review of the literature has revealed no similar cases; we therefore believe this to be the first description of the association between LyP and PHP.
References
- 1 Strodel WE, Thompson NW, Eckhauser FE, Knoe JA. Malignancy and concomitant primary hyperparathyroidism. J Surg Oncol 1988; 37: 10–12.
- 2 Farr HW. Hyperparathyroidism and cancer. CA Cancer J Clin 1976; 26: 66–74.
- 3 Albès B, Bazex J, Bayle-Lebey P, Bennet A, Lamant L. Primary hyperparathyroidism and cutaneous T-cell lymphoma: fortuitous association. Dermatology 2001; 203: 162–164.
- 4 Owen CM, Blewitt RW, Harrison PV, Yates VM. Two cases of primary hyperparathyroidism associated with primary cutaneous lymphoma. Br J Dermatol 2000; 142: 120–123.
- 5
Wang HH,
Myers T,
Lach LJ,
Hsieh Ch-Ch,
Kadin ME.
Cancer increased risk of lymphoid and non lymphoid malignancies in patients with lymphomatoid papulosis.
Cancer
1999; 86: 1240–1245.
10.1002/(SICI)1097-0142(19991001)86:7<1240::AID-CNCR19>3.0.CO;2-X CAS PubMed Web of Science® Google Scholar
- 6 Goldsmith RS. Differential diagnosis of hypercalcemia. N Engl J Med 1966; 274: 674–678.
- 7 Mundy GR, Raisz LG, Cooper RA. Evidence for secretion of an osteoclast stimulating factor in myeloma. N Engl J Med 1976; 291: 1041–1046.
- 8 Seyberth HW, Sergre GV, Morgan JL. Prostaglandins as mediators of hypercalcemia associated with certain types of cancer. N Engl J Med 1975; 293: 1278–1283.
- 9 Johnston SR, Hammond PJ. Elevated serum parathyroid hormone related protein and 1,25-dihydroxycholecalciferol in hypercalcaemia associated with adult T-cell leukaemia. Postgrad Med J 1992; 68: 753–755.
- 10 Nosaka K, Miyamoto T, Sakai T et al. Mechanism of hypercalcemia in adult T-cell leukemia: overexpression of receptor activator of nuclear factor kappaB ligand on adult T-cell leukemia cells. Blood 2002; 99: 634–640.
- 11 Richard V, Lairmore MD, Green PL et al. Severe combined immunodeficient/Beige mouse model of adult T-cell lymphoma independent of human T-cell lymphotropic virus type-1 Tax expression. Am J Pathol 2001; 158: 2219–2228.
- 12 McCarty MF. Parathyroid hormone may be a cancer promoter – An explanation for decrease in cancer risk associated with ultraviolet light calcium, and vitamin D. Med Hypotheses 2000; 54: 475–482.
- 13 Levi E, Wang Z, Petrogiannis-Haliotis T et al. Distinct effects of CD30 and Fas signaling in cutaneous anaplastic lymphomas: a possible mechanisms for disease progression. J Invest Dermatol 2000; 115: 1034–1040.
- 14 Wang W, Johansson H, Kvansnicka T, Farnebo LO, Grimelius L. Detection of apoptotic cells and expression of Ki-67 antigen, bcl-2, p53 oncoproteins in human parathyroid adenoma. APMIS 1996; 104: 789–796.
- 15 Mao X, Lillington D, Scarisbrick JJ et al. Molecular cytogenetic analysis of cutaneous T-cell lymphomas: identification of common genetic alterations in Sézary syndrome and mycosis fungoides. Br J Dermatol 2002; 147: 464–475.
- 16 Dereure O, Levi E, Vonderheid EC, Kadin ME. Infrequent Fas mutations but no Bax or p53 mutations in early mycosis fungoides: a possible mechanisms for the accumulation of malignant T lymphocytes in the skin. J Invest Dermatol 2002; 118: 949–956.
- 17 Nevala H, Karenko L, Vakeva L, Ranki A. Proapoptotic and antiapoptotic markers in cutaneous T-cell lymphoma skin infiltrates and lymphomatoid papulosis. Br J Dermatol 2001; 145: 928–937.
- 18 Kikuchi A, Nishikawa T. Apoptotic and proliferating cells in cutaneous lymphoproliferative diseases. Arch Dermatol 1997; 133: 829–833.
- 19 Thomapoulou GE, Tseleni-Balagouta S, Lazaris AC, Koutselini H, Kavantzas N, Davoris PS. Immunohistochemical detection of cell cycle regulators, Fhit protein and apoptotic cells in parathyroid lesions. Eur J Endocrinol 2003; 148: 81–87.
- 20 Willemze R, Kerl H, Sterry W et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 1997; 90: 354–371.
Citing Literature
